Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Brian Piekos, officer

Transaction date: Feb. 21, 2026

Reporting date: Feb. 24, 2026

Average share price: -8.508053077636871

Sold 3233.0 shares for 27506.54